In the early stages of MSA, levodopa and drugs that act directly on dopamine ... On average, however, these drugs are less effective in patients with MSA compared to those with Parkinson's disease.

The condition affects adults primarily older than 65. Though Parkinson’s disease itself is separated into five stages, Parkinson’s disease dementia isn’t as well understood. People with ...

And it's these combinations of atrophy and hypertrophy that are ... to quantify brain changes associated with the stages of Parkinson's disease, the study could have several implications, starting ...

Other clinical-stage drugs in the category include ... 341 which disappointed in a phase 2 trial in Parkinson's, but remains in development for MSA; and Novartis and UCB's oral candidate ...

Previous research by the team has shown this technique is able to distinguish between Parkinson’s and multiple system atrophy ... skin even at the earliest stages.” The team said further ...

and MSA-P (parkinsonian type) which has more parkinsonian symptoms but is relatively unresponsive to the usual therapy for Parkinson’s disease (i.e., levodopa). Some of the atypical parkinsonian ...